LALília Andrade

Lília Andrade

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lília Andrade has a total of 73 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Functional Status Following Pulmonary Rehabilitation: Responders and Non-Responders

    by Sara Souto-Miranda, Maria A. Mendes, João Cravo, Lília Andrade, Martijn A. Spruit, Alda Marques

    The 6 min walking test (6MWT) has been largely studied. Less is, however, known about responders and non-responders to pulmonary rehabilitation (PR) in other meaningful activities. We explored responders and non-responders and the predictors of response to PR in the 1 min sit-to-stand test (1 min STS) and the 6MWT and compared both measures in classifying responders. An observational study was conducted with 121 people with chronic obstructive pulmonary disease (COPD). The functional status was assessed before and after PR. Baseline differences between responders and non-responders were tested with Mann–Whitney U, chi-square, or Fisher exact tests. Predictors were explored with binary logistic regressions. Agreement between both measures was assessed with chi-square, Cohen’s kappa, and McNemar tests. There were 54.5% and 57.0% of responders in the 1 min STS and the 6MWT, respectively. The proportion of responders was significantly different (p = 0.048), with a small agreement between the measures (kappa = 0.180; p = 0.048). The baseline 6MWT was the only significant predictor of response in the 6MWT (OR = 0.995; pseudo-r2 = 0.117; p < 0.001). No significant predictors were found for the 1 min STS. A large number of non-responders in terms of functional status exist. The 1 min STS and the 6MWT should not be used interchangeably. Future studies should explore the added benefit of personalizing PR to this outcome and investigate other potential predictors.


  • Open Access

    What Motivates Patients with COPD to Be Physically Active? A Cross-Sectional Study

    by Sara Pimenta, Cândida G. Silva, Sofia Flora, Nádia Hipólito, Chris Burtin, Ana Oliveira, Nuno Morais, Marcelo Brites-Pereira, Bruno P. Carreira, Filipa Januário, et al.

    Motivation can be broadly defined as what moves people to act. Low motivation is a frequently reported factor for the reduced physical activity (PA) levels observed in patients with chronic obstructive pulmonary disease (COPD). This study assessed patients’ motives to be physically active, according to three pulmonary rehabilitation (PR) participation groups (Never PR, Previous PR and Current PR) and explored whether these motives were related to the PA levels and clinical characteristics. The motives to be physically active were assessed with the Exercise Motivation Inventory-2 (EMI-2, 14 motivational factors, five dimensions) and PA with accelerometry (PA groups: 0.05) but having less symptoms and ≥two comorbidities were associated with higher scores in psychological/health and body-related motives, respectively (p < 0.05). The findings may encourage health professionals to actively explore with patients their motives to be physically active to individualise PA promotion.


  • Functional ability in patients with COPD

    by Ana Filipa Machado, Sara Souto-Miranda, Ana Tavares, Ana Oliveira, Cristina Jácome, Joana Cruz, Bruno Cabrita, Catarina Cascais Costa, Carla Valente, Vitória Martins, et al.

    Background: Functional impairment is a critical consequence of COPD. The 1-minute sit-to-stand (1STS) is a valid and reliable test to measure this health domain in patients with COPD, with established reference values. We aimed to quantify the prevalence of functional impairment in patients with COPD and identify the distribution of this impairment across disease stages. Methods: A cross-sectional study with patients with COPD and healthy age-/gender-matched controls was conducted. Spirometry, the modified British Medical Research Council questionnaire (mMRC) and the 1STS were collected. Patients were grouped by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) classifications. Differences between groups were explored with Kruskal-Wallis and Bonferroni-adjusted pairwise comparisons. Results: 366 patients with COPD (76% male, 67±10y, FEV1 56±21pp) and 345 controls (70% male, 67±9y, FEV1104±21pp) participated. 50% of the patients presented functional impairment (i.e., performed below 80%predicted). Patients with COPD presented lower functional ability than controls, independently of the GOLD grade/group (Fig. 1). The most symptomatic patients (i.e., GOLD B and D) had the lowest functional levels. Conclusion: Functional ability is reduced in patients with COPD in all GOLD grades/groups, especially in the most symptomatic. Future studies should explore therapeutic interventions to address this problem.

  • Clinical characteristics of COPD Phenotypes

    by Alda Sofia Pires De Dias Marques, Ana Machado, Sara Souto-Miranda, Crsitina Jácome, Joana Cruz, Ana Oliveira, Vera Enes, Vera Afreixo, Vitória Martins, Lília Andrade, et al.

    Comprehensive understanding of COPD phenotypes, incorporating simple, widely used and meaningful outcomes (e.g., functional status), might contribute to personalise patients’ assessment and management. We described COPD phenotypes and developed a classification tree for its prediction. A cross-sectional study was conducted with patients with COPD. Data collection included airway obstruction (FEV1pp); comorbidities (Charlson comorbidity index); functional status (one-minute sit-to-stand test [1-minSTS]) and impact of the disease (COPD assessment test [CAT]). Clustering analysis using k-medoids was used to explore existent phenotypes. A classification tree was generated with 70% of the sample. The remaining 30% was used for its validation, i.e., to determine its prediction ability to identify the correct phenotype. Accuracy/agreement (Cohen’s Kappa) were determined. 364 patients with COPD (67yrs; 76%male; FEV1 57±21pp) participated. Four phenotypes (C1, C2, C3, C4) were found (Fig. 1): two presenting severe (C1, C4) and two mild-to-moderate (C2, C3) airflow obstruction; two low (C1, C2) and two high (C3, C4) impact of the disease; two low (C3, C4) and two high (C1, C2) functional status. The classification tree established cut-offs for these variables and correctly classified 85% of new individuals in their phenotype (Cohen’s Kappa=0.8). Meaningful and easily available assessments were able to differentiate COPD phenotypes and may guide patient-centred interventions.

  • Reliability and validity of the international physical activity questionnaire short-form (IPAQ-sf) in COPD

    by Sofia Flora, Nádia Hipólito, Liliana Santos, Filipa Januário, Sónia Silva, Carla Valente, Lília Andrade, Fátima Rodrigues, Alda Marques, Joana Cruz

    Physical activity (PA) may improve COPD prognosis, thus its assessment and promotion are crucial. The International Physical Activity Questionnaire Short-Form (IPAQ-sf) is widely used for assessing PA but there is limited evidence on its clinimetric properties in COPD. We assessed the test-retest reliability and validity of the IPAQ-sf in patients with COPD. Fifty-five participants (68.6±7.8yrs, 48 males, FEV1 52.3±22.5%pred) completed the IPAQ-sf, wore an accelerometer for 7 days and completed a second IPAQ-sf. Test-retest reliability/agreement was assessed with: Intraclass Correlation (ICC, 95%CI), 95% Limits of Agreement (LoA), standard error of measurement (SEM) and minimal detectable change (MDC95) for continuous variables; %agreement for categories (“active” vs “inactive”). Validity was assessed with Spearman’s correlations (ρ) between the IPAQ-sf (METs-min/week, time in vigorous [VPA] and moderate PA [MPA] per week) and accelerometry [time in MVPA, VPA and MPA per week] for continuous variables; %agreement, Cohen’s kappa, sensitivity and specificity (95%CI) for categories. Reliability was acceptable (ICC=0.738, 0.629→0.873) but with wide LoA (-5713→4793.3 METs-min/week). SEM and MDC95 were 1844.7 and 5113.3 METs-min/week, respectively. %agreement of the two IPAQ-sf was 85.5% (kappa=0.660, 0.444→0.876). Significant correlations were found between METs-min/week and accelerometry (0.515≤ρ≤0.596), except for VPA (p>0.05). %agreement between tools was 67.3% (kappa=0.350, 0.279→0.571) with high sensitivity (0.89, 0.887→0.891) but low specificity (0.46, 0.46→0.47). The IPAQ-sf could be used as PA measurement tool in COPD although caution is needed to avoid misclassification.


  • Open Access

    Minimal Clinically Important Differences for Patient-Reported Outcome Measures of Cough and Sputum in Patients with COPD

    by Patrícia Rebelo, Ana Oliveira, Cátia Paixão, Carla Valente, Lília Andrade, Alda Marques

    Background: Cough and sputum are highly prevalent in patients with chronic obstructive pulmonary disease (COPD). Pulmonary rehabilitation (PR) has shown to be effective in managing these symptoms. However, the interpretation of the magnitude of PR effects is hindered by the lack of minimal clinically important differences (MCIDs). Purpose: This study established MCIDs for the Leicester cough questionnaire (LCQ) and the cough and sputum assessment questionnaire (CASA-Q), in patients with COPD after PR. Patients and Methods: An observational prospective study was conducted in patients with COPD who participated in a 12-weeks community-based PR program. Anchor- (mean change, receiver operating characteristic curves and linear regression analysis) and distribution-based methods [0.5*standard deviation; standard error of measurement (SEM); 1.96*SEM; minimal detectable change and effect size] were used to compute the MCIDs. The anchors used were: i) patients and physiotherapists global rating of change scale, ii) COPD assessment test, iii) St. George’s respiratory questionnaire and iv) occurrence of an exacerbation during PR. Pooled MCIDs were computed using the arithmetic weighted mean (2/3 for anchor- and 1/3 for distribution-based methods). Results: Forty-nine patients with COPD (81.6% male, 69.8± 7.4years, FEV1 50.4± 19.4%predicted) were used in the analysis. The pooled MCIDs were 1.3 for LCQ and for CASA-Q domains were: 10.6 - cough symptoms; 10.1 - cough impact; 9.5 - sputum symptoms and 7.8 - sputum impact. Conclusion: The MCIDs found in this study are potential estimates to interpret PR effects on cough and sputum, and may contribute to guide interventions.


  • Pulmonary rehabilitation closer to patients – feasibility and effectiveness study

    by Alda Sofia Pires De Dias Marques, Patrícia Rebelo, Cátia Paixão, Cristina Jácome, Joana Cruz, Marília Rua, Helena Loureiro, Célia Freitas, Carla Valente, Pedro Ferreira, et al.

    Pulmonary Rehabilitation (PR) remains highly inaccessible to patients with chronic respiratory diseases (CRD). We assessed the effects of a minimal-resource community-based PR programme in patients with CRD. Seventy-seven patients (48 male;68±11yrs;57.7±22.2%FEV1%predicted; 80.3±19.6FVC%predicted) with COPD(n=52), asthma(n=13), asthma-COPD overlap(n=3), interstitial lung disease(n=7), lung transplant due to COPD(n=1) and bronchiectasis(n=1) participated in a 12-week community-based PR programme. The modified Medical Research Council–dyspnoea scale (mMRC), Saint George’s Respiratory Questionnaire (SGRQ), quadriceps muscle strength (QMS), 1-minute sit-to-stand (1-minSTS), six-minute walk test (6MWT), Brief Balance Evaluation System Test (Brief-BESTest) and Hospital Anxiety and Depression Scale (HADS) were collected pre/post PR. Differences were examined using the Student’s t-test/Wilcoxon test and effect sizes (ES) were calculated. The number of patients improving above the minimal clinically important difference (MCID) was established, whenever a MCID was available. Significant improvements were observed (Figure 1). The number of patients above the MCID were: 33 in mMRC(1 point), 47 in SGRQ(4 points); 41 in 1min-STS(3 repetitions); 50 in the 6MWT(25m), 18 in the Brief-BESTest(4.9 points) and 32 and 28 in the HADS Anxiety and Depression scores(1.5 points). Community-based PR programmes are feasible and effective in patients with CRD.


  • Airway Microbiota diversity and composition correlates with severity of Chronic Obstructive Pulmonary Disease (COPD)

    by Sara Dias, Filipa Machado, Carla Valente, Lilia Andrade, Alda Marques, Ana Sousa

    COPD occurrence is mediated by immune response, environmental factors and microbial dysbiosis. Airway microbiota has been found to be different between healthy people and patients with COPD and these differences could influence disease severity. But, its clinical implications are still unclear. Here, we have explored the airway microbiota of patients with COPD as well as its relations with specific clinical parameters. 40 patients (35?, 67±9y, FEV1pp 33±7, GOLD III-26, IV-14) and 40 healthy controls (34?, 67±12y, FEV1pp 101±19) were recruited and sociodemographic, anthropometric and clinical data were collected. Saliva microbiota was characterised by 16S rRNA sequencing and analysed using Qiime2 pipeline. Significant differences in airway microbiota composition between patients and healthy people were observed (Fig 1). The microbiota of patients with worse clinical parameters, like lower FEV1pp and SpO2, or with higher number of exacerbations and hospitalisations, clustered separately from less severe. Loss of microbiota diversity correlated with age in patients, but not in healthy people, raising the hypothesis of the cumulative use of antibiotics (by patients) contributing to dysbiosis. The association between microbiota composition and clinical parameters supports its contribution to COPD trajectory. Future studies should focus on remodelling patients’ dysbiotic microbiotas towards healthier ensembles aiming at preventing disease decline.

  • Enhancing the understanding of the time course of AECOPD.

    by Ana Luisa Araújo Oliveira, Vera Afreixo, Carla Valente, Lília Andrade, Alda Marques

    Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are associated with pulmonary/systemic changes, however quantification of those changes during AECOPD and factors influencing recovery are lacking. This study characterised patients’ evolution during AECOPD and identified factors influencing their recovery. 44 outpatients with AECOPD (31♂; 68.2±9.1y; 51.1±20.3 FEV1%predicted) were enrolled. Body mass index (BMI) and modified medical research council–dyspnea (mMRC) (independent variables) were collected within 24-48h of hospital presentation (T1) and quadriceps muscle strength (QMS, handheld dynamometry), 5 times sit-to-stand (5STS) and COPD Assessment (CAT) tests (dependent variables) were collected at T1 and at days 8 (T2), 15 (T3) and 45 (T4) after T1. Generalized Estimating Equations were used for analysis. QMS, 5STS and CAT improved overtime (p<.05). QMS was lower in dyspneic (mMRC≥2; 24.3±11.7%predicted; p<.05) patients. CAT scores were higher in overweight (BMI≥25; 4.6±1.8; p<.05) and dyspneic (8.0±1.8; p<.05) patients. Changes in 5TSS during AECOPD were influenced by BMI and dyspnea, whilst changes in CAT were influenced only by BMI (p<.05). No influences were observed in QMS. Results are in Fig.1. Significant changes on muscle strength, functionality and impact of the disease occur during an AECOPD. BMI and mMRC values at the onset seem to be factors playing a key role on patients’ recovery from an AECOPD.